Chloracne.
Schlessinger DI, Robinson CA, Schlessinger J.
2022 Oct 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands.
Furue M, Tsuji G.
Int J Environ Res Public Health. 2019 Dec 3;16(23):4864. doi: 10.3390/ijerph16234864.
Chloracne.
Singh S, Manoj R, Gupta A.
JAMA Dermatol. 2024 Jun 1;160(6):668-669. doi: 10.1001/jamadermatol.2024.0928.
Chloracne and chloracnegens.
Tindall JP.
J Am Acad Dermatol. 1985 Oct;13(4):539-58. doi: 10.1016/s0190-9622(85)70196-x.
Chloracne, a misnomer and its implications.
Saurat JH, Sorg O.
Dermatology. 2010 Aug;221(1):23-6. doi: 10.1159/000290672. Epub 2010 Apr 30.
Chloracne.
BECHET PE.
Arch Derm Syphilol. 1946 Dec;54(6):728.
Dioxin-induced chloracne--reconstructing the cellular and molecular mechanisms of a classic environmental disease.
Panteleyev AA, Bickers DR.
Exp Dermatol. 2006 Sep;15(9):705-30. doi: 10.1111/j.1600-0625.2006.00476.x.
Toward elucidation of dioxin-mediated chloracne and Ah receptor functions.
Bock KW.
Biochem Pharmacol. 2016 Jul 15;112:1-5. doi: 10.1016/j.bcp.2016.01.010. Epub 2016 Jan 23.
Chloracne in the 1990s.
Rosas Vazquez E, Campos Macias P, Ochoa Tirado JG, Garcia Solana C, Casanova A, Palomino Moncada JF.
Int J Dermatol. 1996 Sep;35(9):643-5. doi: 10.1111/j.1365-4362.1996.tb03689.x.
Chloracne. Clinical manifestations and etiology.
Zugerman C.
Dermatol Clin. 1990 Jan;8(1):209-13.
